Embed Size (px)
Citation preview
Funded by the Horizon 2020 Framework Programme of the European Union
SNOMED CT© WITHIN A STRATEGY TOWARDSEHEALTH INTEROPERABILITY IN THE EU: OUTCOMES OF ASSESS-CT
Julian SassCompetence Center eHealthUniversity of Applied Science Niederrhein
SEMANTIC INTEROPERABILITY
SNOMED CT ONTOLOGY
22298006
74281007
55641003
myocardial infarction (disorder)
myocardium structure (body structure)
Infarct (morphological abnormality)
finding site
PROJECT MANAGEMENT STRUCTURE
Project Coordination Committee (PCC)
Project Executive Committee (PEC)
Project Coordination (PC)
Work Package Teams
Chaired by the Project coordination
One representative per partner
Chaired by the Project coordination
WP leaders
Scientific Coordinator
S. Thun, UNiederrhein
Leader WP1:
G. Cangioli, HL7 IF
Leader WP3
R. Thiel, empirica
Leader WP5
S. Thun, Uniederrhein | S. Robinson, empirica
Leader WP4
D. Kalra, Eurorec
Leader WP2
S. Schulz, MUG
Quality & RiskManager
Admin Management
S. Robinson, empirica
Project Manager
U. Walossek, empirica
D. Kalra, EuroRec
European Commission
Project Officer
Networking
Focus Groups in EU
Member States (MS)
Terminology Responsibles (TR) in all MS
Stakeholders
TR epSOS
Network Coordinators
V. Stroemann, empirica
C. Chronaki, HL7 IF
Expert Panel
ASSESS CT – MAIN OBJECTIVES
o Investigating the use of SCT
o Assessing if SCT satisfies the requirements of EU standardization regulations
o Studying the fitness of SCT as a clinical terminology
o Providing a socio-economical evidence-based assessmentof costs and benefits
o Consolidating the experiences and evidence to develop a national /European strategy for the use of terminologies
o Communicating and disseminating project findings
o Coordinating with the other PHC-34 CSAs
o Carrying out an ethical assessment
WORKPLAN ASSESS CT
OVERVIEW COST INDICATORS
Nr Cost indicatorCosts related to organisational infrastructureC1 License costsC2 Decision making costs for adoption of terminologiesC3 Release management costsC4 National Release Centre (NRC) costsC5 Legacy costs of administrationC6 Promoting ImplementationsCosts related to technical infrastructureC7 Translation costsC8 Mapping costsC9 Customisation costsC10 Implementation testing costs (user pilots, user interface)C11 Integration into software productsC12 Terminology Binding CostsCost related to capacity-buildingC13 Skills Development and Training costsC14 Educational material costsCost related to toolsC15 Terminology management system (TMS) costs
OVERVIEW BENEFIT CATEGORIES
Nr Benefit categories
B1 Terminology across professional boundaries
B2 Enhancing clinical decision support systems and medication procedures
B3 Patient-friendly terms for complex medical language
B4 More detailed administrative reporting
B5 Analytics for clinical audits, population health management and research
B6 Interlingua standard supporting vendors and users
B7 Enabling cross-border interoperability
B8 Up-to-date terminology supporting open-ended needs
BENEFIT: ANNOTATING VALUE SETS
o Methods
− ADOPT: SNOMED CT only
− ALTERNATIVE: UMLS subset
− ABSTAIN: local German terminologies
Rare Diseases EmergencyRoomProtocol Notifiable Agents epSOSReactionAllergy epSOSVaccine
ADOPT ALTERNATIVE ABSTAIN
A European terminology strategy should be part of an overarching European
eHealth strategy. The strategy should support the principles of collecting clinical
data once and using them multiple times, where allowed and required. Thus,
administrative, public health and research information should almost always be
derived from routinely collected clinical information.
This strategy should have Member State commitment and should consider human
and financial resource implications, incentives, as well as technical and semantic
requirements.
A main advantage is its content coverage, which is superior to any other single
terminology, making it the most complete point of reference for health related
concepts. Another advantage of SNOMED CT over a set of other clinical
terminologies is its principled ontology-based architecture with a logic-based
coordination syntax.
No country sees SNOMED CT as a standalone solution, but rather as an important
part of the national terminology infrastructure.
Such incremental use, but across all Member States, might be subject to specially
negotiated licences on behalf of the whole of Europe.
Solutions must be in place for legacy conversion, guaranteeing the continued
exploitation of historical data, for user interface terminologies, and for assuring the
continuation of global mortality and morbidity statistics.
This should maximise the value of Member State and SDO alignment on the
approach to advancing semantic interoperability, including the implementation and
deployment of SNOMED CT.
THANK YOU FOR YOUR ATTENTION !
THANK YOU FOR YOUR ATTENTION !
contact:
o Prof. Dr. Sylvia Thun, PhD, MD
o Julian Sass
www.assess-ct.eu
